Literature DB >> 18433458

Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells.

W J Cao, M Niiya, X W Zheng, D Z Shang, X L Zheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433458      PMCID: PMC2582585          DOI: 10.1111/j.1538-7836.2008.02989.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

Review 1.  Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.

Authors:  M Furlan; B Lämmle
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

2.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

3.  Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts.

Authors:  Dezhi Shang; X Wu Zheng; Masami Niiya; X Long Zheng
Journal:  Blood       Date:  2006-04-04       Impact factor: 22.113

4.  Localization of ADAMTS13 to the stellate cells of human liver.

Authors:  Masahito Uemura; Kouko Tatsumi; Masanori Matsumoto; Masao Fujimoto; Tomomi Matsuyama; Masatoshi Ishikawa; Taka-Aki Iwamoto; Toshio Mori; Akio Wanaka; Hiroshi Fukui; Yoshihiro Fujimura
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

5.  Von Willebrand factor in patients evolving Q-wave versus non-Q-wave acute myocardial infarction.

Authors:  D Tousoulis; C Tentolouris; E Bosinakou; T Apostolopoulos; M Kyriakides; P Toutouzas
Journal:  Int J Cardiol       Date:  1996-10-25       Impact factor: 4.164

6.  Plasma cytokine levels in thrombotic thrombocytopenic purpura.

Authors:  H Wada; T Kaneko; M Ohiwa; M Tanigawa; S Tamaki; N Minami; H Takahashi; K Deguchi; T Nakano; S Shirakawa
Journal:  Am J Hematol       Date:  1992-07       Impact factor: 10.047

7.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

Review 8.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis.

Authors:  Radu Stefanescu; Dustin Bassett; Rozbeh Modarresi; Francisco Santiago; Mohamad Fakruddin; Jeffrey Laurence
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

10.  Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.

Authors:  Aubrey Bernardo; Chalmette Ball; Leticia Nolasco; Joel F Moake; Jing-fei Dong
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

View more
  42 in total

1.  ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension.

Authors:  Ashish Goel; P L Alagammai; Sukesh C Nair; Ian Mackie; Banumathi Ramakrishna; Jayaprakash Muliyil; Shyamkumar N Keshava; C E Eapen; Elwyn Elias
Journal:  Indian J Gastroenterol       Date:  2014-04-24

Review 2.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

3.  Relative Deficiency of Plasma A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeats 13 Activity and Elevation of Human Neutrophil Peptides in Patients with Traumatic Brain Injury.

Authors:  Monisha A Kumar; Wenjing Cao; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Eileen Maloney-Wilensky; James Schuster; X Long Zheng
Journal:  J Neurotrauma       Date:  2018-08-14       Impact factor: 5.269

4.  von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans.

Authors:  Alexander T Bauer; Jan Suckau; Kathrin Frank; Anna Desch; Lukas Goertz; Andreas H Wagner; Markus Hecker; Tobias Goerge; Ludmila Umansky; Philipp Beckhove; Jochen Utikal; Christian Gorzelanny; Nancy Diaz-Valdes; Viktor Umansky; Stefan W Schneider
Journal:  Blood       Date:  2015-02-24       Impact factor: 22.113

5.  IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system.

Authors:  G Alkistis Frentzou; Claire Bradford; Kirsty A Harkness; Gail Haddock; M Nicola Woodroofe; Alison K Cross
Journal:  J Mol Neurosci       Date:  2011-07-06       Impact factor: 3.444

Review 6.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

7.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

8.  von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis.

Authors:  Georgios N Kalambokis; Gerasimos Baltayiannis; Dimitrios Christodoulou
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

Review 9.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 10.  Pivotal role of ADAMTS13 function in liver diseases.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.